In conclusion, our comparative proteomic approach using CML MDR/IM cross-resistant cell line and its parental cell line identified LRPPRC and MCM7 as putative actors in IM resistance. The gene discussed is LRPPRC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.